936886

Gemini Pharmaceuticals, Inc. — FEI 2432926

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 30, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Commack, NY (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
360321 CFR 211.160(b)Scientifically sound laboratory controls
363221 CFR 211.170(b)Annual visual exams of drug products
436921 CFR 211.188(b)(11)Identification of persons involved, each significant step